Td Private Client Wealth LLC Bluebird Bio, Inc. Transaction History

Td Private Client Wealth LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Aug 16, 2024	SELL	$16.59 - $33.89 $298 - $610	-18 Closed	0 $0
Q4 2020 Aug 16, 2024	SELL	$27.5 - $37.92 $165 - $227	-6 Reduced 25.0%	18 $779,000
Q3 2020 Aug 16, 2024	BUY	$34.44 - $43.75 $619 - $787	18 Added 300.0%	24 $1.3 Million
Q2 2020 Aug 16, 2024	SELL	$27.12 - $45.97 $162 - $275	-6 Reduced 50.0%	6 $366,000
Q1 2020 Aug 16, 2024	BUY	$26.16 - $63.5 $156 - $381	6 Added 100.0%	12 $552,000
Q4 2019 Aug 16, 2024	BUY	$46.96 - $61.67 $281 - $370	6 New	6 $527,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.